Oruka Therapeutics, Inc. (ORKA) compared with its closest peers (OLMA, ZBIO, VERA, VERU, EVMN). Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Olema Pharmaceuticals, Zenas BioPharma, Vera Therapeutics, Veru, Evommune, Crescent Biopharma, Neuphoria Therapeutics, Bicara Therapeutics, Geron and Alumis share Oruka Therapeutics's sub-industry, pharmaceutical makers.
| Company | Market Cap | P/E |
|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | $787.48M | — |
| Zenas BioPharma, Inc. (ZBIO) | $1.97B | — |
| Vera Therapeutics, Inc. (VERA) | $2.52B | — |
| Veru Inc. (VERU) | $39.40M | — |
| Evommune, Inc. (EVMN) | $382.52M | — |
| Crescent Biopharma, Inc. (CBIO) | $717.99M | — |
| Neuphoria Therapeutics Inc. (NEUP) | $20.16M | — |
| Bicara Therapeutics Inc. (BCAX) | $1.51B | — |
| Geron Corporation (GERN) | $864.13M | — |
| Alumis Inc. (ALMS) | $1.17B | — |
| Sector P/E (Healthcare) | 19.4 |
| Industry P/E (Pharmaceutical Products) | 15.1 |
ORKA overview · ORKA earnings · ORKA financials · ORKA KPIs · ORKA documents · ORKA ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.